Back
Karyopharm Therapeutics Quote, Financials, Valuation and Earnings
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
28
KPTI
Karyopharm Therapeutics
Last Price:
0.85
Seasonality Move:
-2.8%
7 Day Trial
ALL ACCESS PASS
$
7
Say this - unlock as much as $1,250 every Friday
Click here for full details.Karyopharm Therapeutics Price Quote
$0.85
+0.07 (+9.31%)
(Updated: November 22, 2024 at 5:55 PM ET)
Karyopharm Therapeutics Key Stats
Sell
28
Karyopharm Therapeutics (KPTI)
is a Sell
Day range:
$0.76 - $0.80
52-week range:
$0.62 - $1.95
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.67
P/B ratio:
0%
Volume:
278.5K
Avg. volume:
781K
1-year change:
5.34%
Market cap:
$97.4M
Revenue:
$146M
EPS:
$-1.14
How Much Does Karyopharm Therapeutics Make?
-
How Much Are Karyopharm Therapeutics's Sales Annually?
KPTI Revenues are $146M -
How Much Profit Does Karyopharm Therapeutics's Make A Year?
KPTI net income is -$143.1M
Is Karyopharm Therapeutics Growing As A Company?
-
What Is Karyopharm Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.08% -
What Is Karyopharm Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Karyopharm Therapeutics Stock Price Performance
-
Did Karyopharm Therapeutics Stock Go Up Last Month?
Karyopharm Therapeutics share price went down by -8.99% last month -
Did KPTI's Share Price Rise Over The Last Year?
KPTI share price rose by 5.34% over the past 1 year
What Is Karyopharm Therapeutics 52-Week High & Low?
-
What Is Karyopharm Therapeutics’s 52-Week High Share Price?
Karyopharm Therapeutics has traded as high as $1.95 over the past 52 weeks -
What Is Karyopharm Therapeutics’s 52-Week Low Share Price?
Karyopharm Therapeutics has traded as low as $0.62 over the past 52 weeks
Karyopharm Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Karyopharm Therapeutics?
-
How Much Debt Does Karyopharm Therapeutics Have?
Total long term debt quarterly is $190.6M -
How Much Cash Does Karyopharm Therapeutics Have?
Cash and short term investments quarterly total is $133.5M -
What Is Karyopharm Therapeutics’s Book Value Per Share?
Book value per share is -1.27
Is Karyopharm Therapeutics Cash Flow Positive?
-
What Is KPTI Cash Flow From Operations?
Cash flow from operations (TTM) is -$120.3M -
What Is Karyopharm Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $0 -
What Is Karyopharm Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $107.5M
Karyopharm Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
KPTI return on invested capital is -221.89% -
What Is Karyopharm Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -39.11% -
What Is KPTI Return On Equity?
ROE is a measure of profitability and is 0%
Karyopharm Therapeutics Earnings Date & Stock Price
-
What Is Karyopharm Therapeutics's Stock Price Today?
A single share of KPTI can be purchased today for 0.78 -
What Is Karyopharm Therapeutics’s Stock Symbol?
Karyopharm Therapeutics trades on the nasdaq under the ticker symbol: KPTI -
When Is Karyopharm Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Karyopharm Therapeutics is scheduled on February 28, 2025 -
When Is KPTI's next ex-dividend date?
Karyopharm Therapeutics's next ex-dividend date is November 23, 2024 -
How To Buy Karyopharm Therapeutics Stock?
You can buy Karyopharm Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Karyopharm Therapeutics Competitors
-
Who Are Karyopharm Therapeutics's Competitors?
Below is a list of companies who compete with Karyopharm Therapeutics or are related in some way:
Karyopharm Therapeutics Dividend Yield
-
What Is KPTI Dividend Yield?
Karyopharm Therapeutics’s dividend yield currently is 0% -
What Is Karyopharm Therapeutics’s Payout Ratio?
Karyopharm Therapeutics’s payout ratio is 0% -
When Did Karyopharm Therapeutics Last Pay A Dividend?
The latest dividend pay date is November 23, 2024 -
What Is Karyopharm Therapeutics’s Dividend Per Share?
Karyopharm Therapeutics pays a dividend of $0.00 per share
Karyopharm Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 0.64% |
| Revenue: | 7.7% | 2.27% |
Analyst Recommendations
| Buy Recommendations: | 2 |
|---|---|
| Hold Recommendations: | 1 |
| Sell Recommendations: | 0 |
| Price Target: | 4.50 |
| Upside from Last Price: | 478.7% |